Error message

The page you requested does not exist. For your convenience, a search was performed using the query Surgical Oncology.

Page not found

Search results

  1. Meet with... Astellas Venture Management

    areas, including: Immunology and Inflammation, Urology, Oncology, DM Complications, and Neuroscience ... deals include Cancer Research UK (oncology target discovery), Harvard Medical School (ophthalmology ... target discovery), Dana-Farber Cancer Institute (oncology drug discovery) and Proteostasis (genetic ...

  2. [North Carolina session] Meet with Johnson & Johnson Innovation

    Surgery       - Robotics       - Oncology Vision care Pharmaceutical Oncology Immunology Infectious ... Johnson & Johnson Innovation read bio» Bob Radinsky | Vice President, Oncology Scientific Innovation, ... of Merck Research Laboratories. Prior to that, he held the positions of Director of Oncology and Director ...

  3. The Future of Healthcare: An Evolution or Revolution?

    in areas such as medication adherence, mental health, cardiovascular health and surgical recovery. Diego ...

  4. Johnson & Johnson Innovation Launches Advancing the Safe Use of Healthcare Products QuickFire Challenge

    that help inform patients and consumers, simulate surgical procedures, and ensure proper storage and use ...

  5. Johnson & Johnson Innovation Announces New Collaboration with Texas Medical Center to Spur Development of Breakthrough Medical Device Technologies

    devoted to surgical medical devices used to treat patients, helping to make more options commercially ...

  6. [New Orleans session] Meet with… Johnson & Johnson Innovation

    Innovation read bio» Bob Radinsky | Vice President, Oncology Scientific Innovation, Janssen R&D, LLC read ... Johnson Innovation, Boston. He focuses primarily on the areas of Oncology and Immunology. A trained ... of Immunology, Inflammation and Oncology and has a passion for implementing cutting edge scientific discoveries ...

  7. Meet with... Johnson & Johnson Innovation

    read bio» Bob Radinsky | Vice President, Oncology Scientific Innovation, Janssen R&D, LLC read bio» ... at the Johnson & Johnson Innovation, Boston. He focuses primarily on the areas of Oncology and Immunology. ... on the areas of Immunology, Inflammation and Oncology and has a passion for implementing cutting edge ...

  8. Meet with... Astellas Venture Management

    Immunology and Inflammation, Urology, Oncology, Nephrology and Neuroscience Ophthalmology, Hearing Loss, ... Cancer Center (oncology drug discovery), Potenza (Immune oncology drug discovery) and Kanyos Therapeutics ... Cancer Research UK (oncology target discovery), Harvard Medical School (ophthalmology target discovery), ...

  9. Spotlight on JLABS | February 2015

    President, CEO; Mohit Trikha, EVP, CSO, Head of R&D Grant Gibson, CFO Focus: Oncology therapeutics ... Triphase is an IND – Phase II, capital efficient, proof of concept focused oncology accelerator. Triphase ... in-licenses clinically enabled oncology assets with high value potential and develops them in a shared risk ...

  10. [Licensees’ only event] Pitch Deck Review with Vinay Bhaskar, MPM Capital

    Bhaskar:  Vinay joined MPM in 2016 after leading External R&D for the Oncology therapeutic area ... Merck and Xencor. During this time he also led internal immuno-oncology strategy discussions and served ... as executive sponsor and/or board observer for several Amgen Ventures investments, including Surface Oncology ...

Pages

Share